Overcoming Volume And Viscosity Barriers In Biologic Formulations

The pharmaceutical and healthcare sector is evolving due to key trends: rising chronic disease rates, a shift toward home-based care, growth in biologics, and a transition from intravenous (IV) to subcutaneous (SC) drug delivery. These developments present major formulation and delivery challenges. Biologics like mAbs require higher volumes and concentrations to ensure stability and reduce dosing frequency, often leading to high viscosity.

Traditional containers are often unsuitable for addressing these hurdles. They fail to mitigate drug compatibility risks, which can potentially impact product stability over time and patient safety.

Watch this webinar and discover how to:

• Select the right containment solution for high-viscosity drugs;
• Ensure compatibility and reliable performance with drug delivery devices;
• Enhance patient comfort with smooth, safe injections.